NETWORK & LEARN WITH YOUR PHARMA CONTRACT MANUFACTURING COMMUNITY!

Beyond the Contract:  Navigating from Transactional Outsourcing to Value-Creating Partnerships

Once regarded primarily as a means of increasing capacity and reducing costs, today's Contract Manufacturing Organisations provide the expertise, agility and precision that enable pharmaceutical companies to accelerate innovation and bring life-saving therapies to market.
 
However, as geopolitical uncertainty and ongoing capacity constraints continue to reshape global supply chains, the race to deliver medicines has become increasingly complex.  Against this backdrop, establishing successful outsourcing partnerships has become problematic. Pharma companies are looking for partners that can help them stay on the racing line through changing conditions. Meanwhile, CMOs are balancing rising expectations with fluctuating demand, capacity constraints and a complex regulatory landscape.  

The Pharma Contract Manufacturing Conference has been designed to explore these tensions, providing a trusted environment for pharma companies and CDMO's to collaborate and build resilient partnerships that go beyond the contract.

Understanding the Future of the Pharma Contract Manufacturing Market

• Market Insights: Learn how the global CMO/CDMO market is projected to reach $310.9 billion by 2030, driven by demand for outsourcing and innovative drugs.
• Digital Transformation: Discover how AI, IoT, and smart manufacturing are revolutionising operational efficiency and regulatory compliance.
• Sustainability: Explore how green chemistry, carbon neutrality, and sustainable packaging are redefining industry standards.
• Geopolitical Complexities: Understand how regulations like the BIOSECURE Act and regional strategies are reshaping supply chain resilience.
• Innovation: Learn about the role of additive manufacturing, predictive analytics, and lights-out manufacturing in driving future growth.